ZA200408948B - Method of improving absorption of vitamin E by a pet animal - Google Patents
Method of improving absorption of vitamin E by a pet animal Download PDFInfo
- Publication number
- ZA200408948B ZA200408948B ZA200408948A ZA200408948A ZA200408948B ZA 200408948 B ZA200408948 B ZA 200408948B ZA 200408948 A ZA200408948 A ZA 200408948A ZA 200408948 A ZA200408948 A ZA 200408948A ZA 200408948 B ZA200408948 B ZA 200408948B
- Authority
- ZA
- South Africa
- Prior art keywords
- pet
- composition
- promoter
- function
- vitamin
- Prior art date
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title claims description 74
- 238000000034 method Methods 0.000 title claims description 64
- 229930003427 Vitamin E Natural products 0.000 title claims description 37
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 title claims description 37
- 235000019165 vitamin E Nutrition 0.000 title claims description 37
- 229940046009 vitamin E Drugs 0.000 title claims description 37
- 239000011709 vitamin E Substances 0.000 title claims description 37
- 238000010521 absorption reaction Methods 0.000 title claims description 36
- 241001465754 Metazoa Species 0.000 title claims description 30
- 239000000203 mixture Substances 0.000 claims description 57
- 235000005911 diet Nutrition 0.000 claims description 54
- 230000037213 diet Effects 0.000 claims description 50
- 235000013305 food Nutrition 0.000 claims description 36
- 235000019197 fats Nutrition 0.000 claims description 31
- 150000002632 lipids Chemical class 0.000 claims description 31
- 235000012054 meals Nutrition 0.000 claims description 27
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 22
- 210000004347 intestinal mucosa Anatomy 0.000 claims description 22
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical group NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 20
- 230000006870 function Effects 0.000 claims description 17
- 210000004185 liver Anatomy 0.000 claims description 15
- 244000005700 microbiome Species 0.000 claims description 15
- 239000006041 probiotic Substances 0.000 claims description 14
- 235000018291 probiotics Nutrition 0.000 claims description 14
- 108090001060 Lipase Proteins 0.000 claims description 13
- 102000004882 Lipase Human genes 0.000 claims description 13
- 230000004203 pancreatic function Effects 0.000 claims description 13
- 230000000529 probiotic effect Effects 0.000 claims description 13
- 229940088594 vitamin Drugs 0.000 claims description 13
- 229930003231 vitamin Natural products 0.000 claims description 13
- 235000013343 vitamin Nutrition 0.000 claims description 13
- 239000011782 vitamin Substances 0.000 claims description 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 239000000194 fatty acid Substances 0.000 claims description 12
- 229930195729 fatty acid Natural products 0.000 claims description 12
- 150000004665 fatty acids Chemical class 0.000 claims description 12
- 235000015097 nutrients Nutrition 0.000 claims description 12
- 108010024636 Glutathione Proteins 0.000 claims description 11
- 229960003180 glutathione Drugs 0.000 claims description 11
- 229960003080 taurine Drugs 0.000 claims description 11
- 239000004367 Lipase Substances 0.000 claims description 10
- 230000001965 increasing effect Effects 0.000 claims description 10
- 235000019421 lipase Nutrition 0.000 claims description 10
- 230000003908 liver function Effects 0.000 claims description 10
- 210000002966 serum Anatomy 0.000 claims description 10
- 239000013589 supplement Substances 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 239000003002 pH adjusting agent Substances 0.000 claims description 9
- 235000013406 prebiotics Nutrition 0.000 claims description 9
- 102000007544 Whey Proteins Human genes 0.000 claims description 8
- 108010046377 Whey Proteins Proteins 0.000 claims description 8
- 239000002535 acidifier Substances 0.000 claims description 8
- 235000021119 whey protein Nutrition 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 235000013410 fast food Nutrition 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 7
- 239000011707 mineral Substances 0.000 claims description 7
- 235000010755 mineral Nutrition 0.000 claims description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 6
- 239000000787 lecithin Substances 0.000 claims description 6
- 235000010445 lecithin Nutrition 0.000 claims description 6
- 229940067606 lecithin Drugs 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 102000010445 Lactoferrin Human genes 0.000 claims description 4
- 108010063045 Lactoferrin Proteins 0.000 claims description 4
- 102000004895 Lipoproteins Human genes 0.000 claims description 4
- 108090001030 Lipoproteins Proteins 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 4
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 4
- 230000031891 intestinal absorption Effects 0.000 claims description 4
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 4
- 229940078795 lactoferrin Drugs 0.000 claims description 4
- 235000021242 lactoferrin Nutrition 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 235000019486 Sunflower oil Nutrition 0.000 claims description 3
- 230000037406 food intake Effects 0.000 claims description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 3
- 239000002600 sunflower oil Substances 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 244000025272 Persea americana Species 0.000 claims description 2
- 235000008673 Persea americana Nutrition 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 238000004945 emulsification Methods 0.000 claims description 2
- 241000209140 Triticum Species 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 241000282326 Felis catus Species 0.000 description 33
- 239000004615 ingredient Substances 0.000 description 27
- 235000019621 digestibility Nutrition 0.000 description 24
- 239000003925 fat Substances 0.000 description 22
- 230000008901 benefit Effects 0.000 description 18
- 235000013372 meat Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 239000000839 emulsion Substances 0.000 description 10
- 235000013882 gravy Nutrition 0.000 description 10
- 210000003608 fece Anatomy 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000032683 aging Effects 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229940040461 lipase Drugs 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000019620 fat digestibility Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 235000021055 solid food Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000010411 cooking Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 206010047631 Vitamin E deficiency Diseases 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 235000007882 dietary composition Nutrition 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 235000020774 essential nutrients Nutrition 0.000 description 4
- 230000002550 fecal effect Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
- 244000298479 Cichorium intybus Species 0.000 description 3
- 235000007542 Cichorium intybus Nutrition 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 235000004213 low-fat Nutrition 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 206010025476 Malabsorption Diseases 0.000 description 2
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 2
- 208000035467 Pancreatic insufficiency Diseases 0.000 description 2
- 102000019280 Pancreatic lipases Human genes 0.000 description 2
- 108050006759 Pancreatic lipases Proteins 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 241000191998 Pediococcus acidilactici Species 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 206010071061 Small intestinal bacterial overgrowth Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000021196 dietary intervention Nutrition 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 230000003636 fecal output Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000009200 high fat diet Nutrition 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000003871 intestinal function Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 235000015816 nutrient absorption Nutrition 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- 229940116369 pancreatic lipase Drugs 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 230000007142 small intestinal bacterial overgrowth Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000193798 Aerococcus Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 241000191953 Kocuria varians Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000186715 Lactobacillus alimentarius Species 0.000 description 1
- 241001134659 Lactobacillus curvatus Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001468189 Melissococcus Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 101100338513 Mus musculus Hdac9 gene Proteins 0.000 description 1
- 241000202223 Oenococcus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191965 Staphylococcus carnosus Species 0.000 description 1
- 241000191973 Staphylococcus xylosus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 241000500332 Tetragenococcus halophilus Species 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 241000202221 Weissella Species 0.000 description 1
- 101100338514 Xenopus laevis hdac9 gene Proteins 0.000 description 1
- 229940095602 acidifiers Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000020930 dietary requirements Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- -1 essential nutrients Chemical compound 0.000 description 1
- 201000007089 exocrine pancreatic insufficiency Diseases 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 230000001200 fecal consistency Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008085 high protein diet Nutrition 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000015263 low fat diet Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 230000036997 mental performance Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229940062190 pancreas extract Drugs 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02076346A EP1350435B1 (en) | 2002-04-05 | 2002-04-05 | Compositions and methods for promoting lipid assimilation in pets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200408948B true ZA200408948B (en) | 2006-05-31 |
Family
ID=27838118
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200408948A ZA200408948B (en) | 2002-04-05 | 2004-11-04 | Method of improving absorption of vitamin E by a pet animal |
| ZA200408953A ZA200408953B (en) | 2002-04-05 | 2004-11-04 | Method and dietary composition for improving lipid digestibility |
| ZA200408956A ZA200408956B (en) | 2002-04-05 | 2004-11-04 | Method and dietary composition for improving fat digestibility |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200408953A ZA200408953B (en) | 2002-04-05 | 2004-11-04 | Method and dietary composition for improving lipid digestibility |
| ZA200408956A ZA200408956B (en) | 2002-04-05 | 2004-11-04 | Method and dietary composition for improving fat digestibility |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20050147649A1 (ja) |
| EP (5) | EP1350435B1 (ja) |
| JP (6) | JP2005521415A (ja) |
| CN (3) | CN1652697B (ja) |
| AT (1) | ATE492166T1 (ja) |
| AU (3) | AU2003224038B2 (ja) |
| BR (4) | BRPI0309003B1 (ja) |
| CA (3) | CA2480446A1 (ja) |
| DE (1) | DE60238663D1 (ja) |
| ES (5) | ES2355890T3 (ja) |
| MX (3) | MXPA04009758A (ja) |
| RU (3) | RU2324365C2 (ja) |
| WO (3) | WO2003084343A2 (ja) |
| ZA (3) | ZA200408948B (ja) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8921422B2 (en) | 2003-10-01 | 2014-12-30 | The Iams Company | Methods and kits for enhancing ability to learn in a puppy or kitten |
| US20050118234A1 (en) * | 2003-12-01 | 2005-06-02 | The Iams Company | Methods and kits related to administration of a fructooligosaccharide |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| EP1952701B2 (en) * | 2004-09-21 | 2020-03-04 | Société des Produits Nestlé S.A. | Improving weight control of elderly pets |
| US8252742B2 (en) | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| CN101150962A (zh) * | 2004-12-30 | 2008-03-26 | 希尔氏宠物营养品公司 | 提高幼年动物生活质量的方法 |
| CA2592844C (en) * | 2004-12-30 | 2012-10-09 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| DK1880001T3 (da) | 2005-05-31 | 2011-09-12 | Iams Company | Feline probiotiske lactobacilli |
| CA2607949C (en) | 2005-05-31 | 2012-09-25 | Thomas William-Maxwell Boileau | Feline probiotic bifidobacteria |
| US20070059297A1 (en) * | 2005-08-04 | 2007-03-15 | Nestec, S.A. | Methods and compositions for improving visual acuity |
| US20090136588A1 (en) * | 2005-12-02 | 2009-05-28 | Hill's Pet Nutrition, Inc. | Methods For Altering Food Intake, Modifying Nutrient Digestibility and Altering Stool Quality and/or Stool Frequency |
| AU2006326040B2 (en) * | 2005-12-15 | 2012-02-09 | Société des Produits Nestlé S.A. | Compositions and methods for preserving brain function |
| GB0602426D0 (en) | 2006-02-07 | 2006-03-22 | Trouw Internat Bv | Feed for fish |
| AU2008211600B8 (en) | 2007-02-01 | 2014-02-13 | Mars, Incorporated | Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts |
| JP5002442B2 (ja) * | 2007-12-20 | 2012-08-15 | 森永乳業株式会社 | 脂質吸収促進剤 |
| US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| WO2009152283A1 (en) * | 2008-06-12 | 2009-12-17 | Professor Connors, Inc. | Pet food treats, pet food treats processing system, and process for making the pet food treats |
| US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
| AU2013200758B2 (en) * | 2008-07-18 | 2014-06-12 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| AU2009270712B2 (en) * | 2008-07-18 | 2013-02-21 | Hill's Pet Nutrition, Inc. | Method for enhancing the quality of life of a senior animal |
| CN102131395B (zh) * | 2008-08-26 | 2014-04-16 | 雀巢产品技术援助有限公司 | 降低食物中淀粉颗粒酶消化速率的方法和该方法生产的食品 |
| GB0818473D0 (en) | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| MX2011007288A (es) * | 2009-01-06 | 2011-09-09 | Nestec Sa | Trozos en composicones alimenticias gelatinosas. |
| MX2011009436A (es) * | 2009-03-11 | 2011-09-27 | Nestec Sa | Trozos en composiciones alimenticias en salsa. |
| JP2010284087A (ja) * | 2009-06-09 | 2010-12-24 | Noji Kumiai Hojin Factor | 鶏卵、鶏卵の生産方法および改良方法、ならびに採卵鶏用飼料 |
| US9173423B2 (en) * | 2009-07-31 | 2015-11-03 | The Iams Company | Animal food kibble with electrostatically adhered dusting |
| US9210945B2 (en) * | 2009-07-31 | 2015-12-15 | The Iams Company | Animal food having low water activity |
| US20110027417A1 (en) | 2009-07-31 | 2011-02-03 | Patrick Joseph Corrigan | Process for Dusting Animal Food |
| US8691303B2 (en) * | 2009-07-31 | 2014-04-08 | The Iams Company | Dusted animal food |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| WO2011046595A1 (en) * | 2009-10-15 | 2011-04-21 | Nestec S.A. | Methods for identifying animals with a reduced ability to digest lipid and protein |
| CN101874570B (zh) * | 2009-11-20 | 2012-06-20 | 天津集合科技有限公司 | 一种宠物食品的外表面喷涂营养组合物及其喷涂方法 |
| US20140147427A1 (en) * | 2011-06-08 | 2014-05-29 | Organobalance Gmbh | Spray-Dried Lactobacillus Stems/Cells and the Use of Same Against Helicobacter Pylori |
| US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
| RU2520840C2 (ru) * | 2011-12-27 | 2014-06-27 | Государственное научное учреждение Всероссийский научно-исследовательский институт мясного скотоводства Российской академии сельскохозяйственных наук | Комплексный пробиотический препарат для крупного рогатого скота мясных пород |
| WO2013101019A1 (en) * | 2011-12-29 | 2013-07-04 | Hill's Pet Nutrition, Inc. | Compositions and methods for modifying gastrointestinal flora |
| JP2014018172A (ja) * | 2012-07-20 | 2014-02-03 | Kohjin Life Sciences Co Ltd | 過酸化脂質生成を抑制するペットフード |
| MX348960B (es) * | 2012-09-13 | 2017-07-04 | Specialites Pet Food | Uso de composiciones grasas para mantener una palatabilidad mejorada de alimentos para animales domesticos en el tiempo. |
| KR101292518B1 (ko) | 2013-01-15 | 2013-08-07 | 조규만 | 분쇄한 식용동물 및 어류와 그 부산물에 호박과 타우린을 함유한 애완동물용 액상사료의 제조방법 |
| CN105815545A (zh) * | 2015-01-06 | 2016-08-03 | 中粮集团有限公司 | 一种有机酸组合物及其应用、制剂 |
| US11304428B2 (en) | 2015-02-16 | 2022-04-19 | Mars, Incorporated | Interlocking kibble |
| CN107529789A (zh) | 2015-04-28 | 2018-01-02 | 马斯公司 | 制备灭菌湿宠物食品的方法 |
| FI3344063T3 (fi) | 2015-09-01 | 2023-01-31 | Menetelmät rasvaliukoisen vitamiinin imeytymisen lisäämiseksi rehussa | |
| KR102604237B1 (ko) * | 2016-06-02 | 2023-11-20 | (주)아모레퍼시픽 | 지용성 비타민 흡수 강화용 조성물 |
| US10052282B2 (en) * | 2016-09-23 | 2018-08-21 | Sydney Baskins | Pet hydration system |
| ES2952868T3 (es) * | 2016-12-15 | 2023-11-06 | Nestle Sa | Composiciones y métodos que modulan la digestibilidad en un animal de compañía |
| JP2023546593A (ja) * | 2020-10-21 | 2023-11-06 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | ペットフード組成物 |
| WO2023114390A2 (en) * | 2021-12-16 | 2023-06-22 | First Wave BioPharma, Inc. | Lipase formulations and methods thereof |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2004409A1 (de) | 1970-01-31 | 1971-09-02 | Keimdiat GmbH, 8900 Augsburg | Natürlicher Wirkstoff fur pharmazeuti sehe und diätetische Zwecke |
| GB1368784A (en) * | 1970-12-09 | 1974-10-02 | Astra Nutrition Ab | Foodstuffs for young animals |
| FR2242935B1 (ja) * | 1973-09-07 | 1978-02-10 | Colgate Palmolive Co | |
| JPS57163313A (en) | 1981-03-31 | 1982-10-07 | Nippon Shinyaku Co Ltd | Vitamin e pharmaceutical and its preparation |
| EP0096902B1 (en) * | 1982-06-16 | 1988-09-28 | Taiyo Fishery Co., Ltd. | Method for the production of protein food products or protein food materials in paste state and method for the production of food products from these materials |
| US4804549A (en) * | 1984-10-25 | 1989-02-14 | Gaines Pet Foods Corp. | Particulate dog food palatability enhancer and process |
| US4963380A (en) | 1987-11-30 | 1990-10-16 | General Mills, Inc. | Beverages containing fish oils stabilized with fructose |
| CH676470A5 (ja) | 1988-02-03 | 1991-01-31 | Nestle Sa | |
| FI892006A (fi) * | 1988-04-29 | 1989-10-30 | Phil Gold | Lactalbumin saosom tillaeggsaemne i mat. |
| JP2677613B2 (ja) | 1988-06-24 | 1997-11-17 | エーザイ株式会社 | ビタミンｅ又はその誘導体の吸収促進組成物 |
| US5053222A (en) | 1989-06-07 | 1991-10-01 | Shiseido Company Ltd. | Hair cosmetic composition |
| EP0421956B1 (en) * | 1989-10-06 | 1993-12-15 | Franca Leo | Food product for domestic animals and a method for its manufacture |
| JPH03219839A (ja) | 1990-01-23 | 1991-09-27 | San Ei Chem Ind Ltd | ペットフードの製造法 |
| JP3347381B2 (ja) | 1993-01-27 | 2002-11-20 | 協和醗酵工業株式会社 | ペットフード |
| GB2277862A (en) | 1993-05-12 | 1994-11-16 | Nutec Ltd | A nutritional composition for oral administration to an animal |
| JPH06319465A (ja) * | 1993-05-13 | 1994-11-22 | Baiotsukusu:Kk | 飼料及びその製造方法 |
| DE4428852C1 (de) * | 1994-08-04 | 1995-10-26 | Heike Koenig | Katzenfutterdressing |
| US5976580A (en) * | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
| US6015798A (en) * | 1995-10-10 | 2000-01-18 | Colgate Palmolive Company | Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
| US5707670A (en) | 1996-08-29 | 1998-01-13 | The Procter & Gamble Company | Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components |
| US5883083A (en) * | 1997-06-09 | 1999-03-16 | Harlmen, Inc. | Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines |
| RU2118494C1 (ru) | 1997-06-24 | 1998-09-10 | Елена Марковна Фатеева | Пищевой продукт |
| US6063414A (en) | 1997-08-18 | 2000-05-16 | Seal Rock Technologies Incorporated | Combination container and dry pet food for increased shelf life, freshness, palatability, and nutritional value |
| US6013665A (en) * | 1997-12-16 | 2000-01-11 | Abbott Laboratories | Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| US6369252B1 (en) * | 1998-02-26 | 2002-04-09 | The University Of Georgia Research Foundation, Inc. | Structured lipids |
| US6149932A (en) * | 1998-03-24 | 2000-11-21 | Stabar Enterprises, Inc. | Dietary supplement for preventing or reducing shedding of hair |
| US6288116B1 (en) | 1998-05-13 | 2001-09-11 | Novartis Nutrition Ag | Method of administration of a nutritional product to a person having renal failure |
| CN1321089A (zh) | 1998-09-08 | 2001-11-07 | 比奥莫勒克拉制品公司 | 增加肠吸收脂肪的方法和组合物 |
| PT1112002E (pt) * | 1998-09-08 | 2002-11-29 | Nestle Sa | Leite em po para animais de estimacao |
| US6156355A (en) | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
| US6254920B1 (en) | 1998-11-24 | 2001-07-03 | Ralston Purina Company | Methods and compositions for enhancing palatability of pet food |
| AU2187700A (en) * | 1998-12-18 | 2000-07-12 | Cp Kelco U.S., Inc. | Gelatin replacement composition |
| US6156354A (en) | 1999-01-29 | 2000-12-05 | Brandeis University | Hyper-absorption of vitamin E dispersed in milks |
| US20030198661A1 (en) | 2000-01-31 | 2003-10-23 | Mars Incorporated | Antioxidant compositions and methods for companion animals |
| GB2367489B (en) | 2000-07-31 | 2005-02-09 | Mars Inc | Use of antioxidants |
| NZ527924A (en) | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
| US6228418B1 (en) * | 1999-04-07 | 2001-05-08 | Cyvex Nutrition | Vegetarian pet treat |
| IL146438A0 (en) * | 1999-05-27 | 2002-07-25 | Iams Company | Process and product for enhancing immune response in companion animal using a combination of antioxidants |
| JP2001136914A (ja) * | 1999-08-30 | 2001-05-22 | Earth Chem Corp Ltd | ペットフード |
| ATE397868T1 (de) | 1999-09-07 | 2008-07-15 | Nestle Sa | Verfahren zur verbesserung der haut und des pelzes von haustieren |
| MY134881A (en) | 1999-09-09 | 2007-12-31 | Nestle Sa | Improving condition of elderly pets |
| US6720001B2 (en) | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| JP2001145464A (ja) | 1999-11-19 | 2001-05-29 | T Hasegawa Co Ltd | 家畜、家禽及びペットフード用飼料添加剤 |
| US6228367B1 (en) * | 1999-12-22 | 2001-05-08 | Renew Life, Inc. | Food supplement formulation |
| US6524619B2 (en) * | 2000-01-27 | 2003-02-25 | Chronorx, Inc. | Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus |
| US20010046493A1 (en) * | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
| HU227182B1 (en) | 2000-03-06 | 2010-09-28 | Andras Javor | Lecitin-ascorbic acid combination |
| US6610007B2 (en) * | 2000-04-03 | 2003-08-26 | Neoguide Systems, Inc. | Steerable segmented endoscope and method of insertion |
| US6946488B2 (en) * | 2000-05-01 | 2005-09-20 | The Iams Company | Pet food composition for reducing inflammatory response in cats |
| AU2001257435B2 (en) * | 2000-05-01 | 2006-01-05 | Mars, Incorporated | Pet food composition for reducing inflammatory response in cats |
| AU6527301A (en) * | 2000-06-01 | 2001-12-11 | United Feeds Inc | Animal food and method |
| US6592863B2 (en) * | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
| AU2001287918A1 (en) | 2000-09-20 | 2002-04-02 | Nycomed Pharma As | Preparation of vitamin emulsions and concentrates thereof |
| US20020119237A1 (en) * | 2000-12-22 | 2002-08-29 | Hevey Maurice O. | Medium and method for delivery of edible materials subject to degradation by oxidation and hydrolysis |
| KR20030088453A (ko) | 2001-03-09 | 2003-11-19 | 소시에떼 데 프로듀이 네슬레 소시에떼아노님 | 연령 관련 생리학적 부전 개선 및 수명 연장을 위한 조성물 |
| EP1243273A1 (en) | 2001-03-22 | 2002-09-25 | Societe Des Produits Nestle S.A. | Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters |
| AU784852B2 (en) * | 2001-08-10 | 2006-07-06 | Mars, Incorporated | Canine support diet |
| US6576667B2 (en) * | 2001-11-14 | 2003-06-10 | Norel Acquisition Corp. | Method for manufacturing fatty acid calcium salts from high glyceride content oils |
| CN1592581A (zh) * | 2001-12-05 | 2005-03-09 | Dsmip资产有限公司 | 宠物喂养中所用的方法和组合物 |
| EP1325682A1 (en) * | 2001-12-11 | 2003-07-09 | Societe Des Produits Nestle S.A. | Food or pet food composition containing plant extracts for maintenance of bone health and prevention or treatment of bone diseases |
| EP1549758B1 (en) * | 2002-05-03 | 2008-07-16 | The Texas A&M University System | Feline pancreatic lipase composition and method of preparing and using such composition |
| AU2005308538A1 (en) * | 2004-08-09 | 2006-06-01 | Enrique Melendez Hevia | Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
-
2002
- 2002-04-05 ES ES02076346T patent/ES2355890T3/es not_active Expired - Lifetime
- 2002-04-05 DE DE60238663T patent/DE60238663D1/de not_active Expired - Lifetime
- 2002-04-05 AT AT02076346T patent/ATE492166T1/de not_active IP Right Cessation
- 2002-04-05 EP EP02076346A patent/EP1350435B1/en not_active Expired - Lifetime
-
2003
- 2003-04-03 US US10/510,126 patent/US20050147649A1/en not_active Abandoned
- 2003-04-03 BR BRPI0309003-5A patent/BRPI0309003B1/pt unknown
- 2003-04-03 EP EP03717271.5A patent/EP1492413B1/en not_active Expired - Lifetime
- 2003-04-03 WO PCT/EP2003/003522 patent/WO2003084343A2/en active Application Filing
- 2003-04-03 AU AU2003224038A patent/AU2003224038B2/en not_active Expired
- 2003-04-03 JP JP2003581600A patent/JP2005521415A/ja active Pending
- 2003-04-03 BR BR0309003-5A patent/BR0309003A/pt active IP Right Grant
- 2003-04-03 US US10/509,949 patent/US20060134090A1/en not_active Abandoned
- 2003-04-03 MX MXPA04009758A patent/MXPA04009758A/es active IP Right Grant
- 2003-04-03 EP EP03718733.3A patent/EP1492414B1/en not_active Expired - Lifetime
- 2003-04-03 CN CN038102382A patent/CN1652697B/zh not_active Expired - Lifetime
- 2003-04-03 ES ES03720422T patent/ES2402091T5/es not_active Expired - Lifetime
- 2003-04-03 JP JP2003581599A patent/JP2005527204A/ja active Pending
- 2003-04-03 JP JP2003581601A patent/JP2006511192A/ja active Pending
- 2003-04-03 RU RU2004132217/13A patent/RU2324365C2/ru active
- 2003-04-03 CA CA002480446A patent/CA2480446A1/en not_active Abandoned
- 2003-04-03 WO PCT/EP2003/003523 patent/WO2003084344A2/en active Application Filing
- 2003-04-03 EP EP08154598.0A patent/EP1952700B1/en not_active Revoked
- 2003-04-03 ES ES03718733.3T patent/ES2528194T3/es not_active Expired - Lifetime
- 2003-04-03 RU RU2004132706/13A patent/RU2316225C2/ru active
- 2003-04-03 RU RU2004132705/13A patent/RU2316224C2/ru active
- 2003-04-03 CN CN038102404A patent/CN1652698B/zh not_active Expired - Lifetime
- 2003-04-03 CA CA2480708A patent/CA2480708C/en not_active Expired - Lifetime
- 2003-04-03 CA CA002480709A patent/CA2480709A1/en not_active Abandoned
- 2003-04-03 ES ES03717271T patent/ES2436208T3/es not_active Expired - Lifetime
- 2003-04-03 BR BR0308995-9A patent/BR0308995A/pt active IP Right Grant
- 2003-04-03 AU AU2003221549A patent/AU2003221549C1/en not_active Expired
- 2003-04-03 CN CN03810234XA patent/CN1652696B/zh not_active Expired - Lifetime
- 2003-04-03 AU AU2003222797A patent/AU2003222797B2/en not_active Expired
- 2003-04-03 MX MXPA04009741A patent/MXPA04009741A/es active IP Right Grant
- 2003-04-03 BR BRPI0309005A patent/BRPI0309005B1/pt active IP Right Grant
- 2003-04-03 EP EP03720422.9A patent/EP1492415B2/en not_active Expired - Lifetime
- 2003-04-03 US US10/509,951 patent/US8475834B2/en active Active
- 2003-04-03 WO PCT/EP2003/003520 patent/WO2003084342A2/en active Application Filing
- 2003-04-03 MX MXPA04009765A patent/MXPA04009765A/es active IP Right Grant
- 2003-04-03 ES ES08154598.0T patent/ES2632951T3/es not_active Expired - Lifetime
-
2004
- 2004-11-04 ZA ZA200408948A patent/ZA200408948B/en unknown
- 2004-11-04 ZA ZA200408953A patent/ZA200408953B/xx unknown
- 2004-11-04 ZA ZA200408956A patent/ZA200408956B/en unknown
-
2008
- 2008-12-09 JP JP2008313520A patent/JP2009082142A/ja active Pending
- 2008-12-09 JP JP2008313528A patent/JP2009114196A/ja active Pending
- 2008-12-09 JP JP2008313593A patent/JP2009142277A/ja active Pending
-
2013
- 2013-06-03 US US13/908,615 patent/US8962007B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8962007B2 (en) | Method of improving absorption of vitamin E by a pet animal | |
| BRPI0308995B1 (pt) | Composition for use in improving or conservation of vitamin absorption and in a pet |